Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease? / Doi, Takahito; Nordestgaard, Børge G.; Langsted, Anne.

I: Current Opinion in Endocrinology, Diabetes and Obesity, Bind 30, Nr. 2, 2023, s. 128-135.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Doi, T, Nordestgaard, BG & Langsted, A 2023, 'Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?', Current Opinion in Endocrinology, Diabetes and Obesity, bind 30, nr. 2, s. 128-135. https://doi.org/10.1097/MED.0000000000000799

APA

Doi, T., Nordestgaard, B. G., & Langsted, A. (2023). Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease? Current Opinion in Endocrinology, Diabetes and Obesity, 30(2), 128-135. https://doi.org/10.1097/MED.0000000000000799

Vancouver

Doi T, Nordestgaard BG, Langsted A. Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease? Current Opinion in Endocrinology, Diabetes and Obesity. 2023;30(2):128-135. https://doi.org/10.1097/MED.0000000000000799

Author

Doi, Takahito ; Nordestgaard, Børge G. ; Langsted, Anne. / Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?. I: Current Opinion in Endocrinology, Diabetes and Obesity. 2023 ; Bind 30, Nr. 2. s. 128-135.

Bibtex

@article{7444721ee3c54c0ba1fcaadb53a9c45d,
title = "Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?",
abstract = "Purpose of reviewTo summarize recent studies analyzing reclassification of estimated risk of myocardial infarction (MI) and ischemic heart disease (IHD) by inclusion of remnant cholesterol (= cholesterol content in triglyceride-rich lipoproteins) in primary and secondary prevention settings.Recent findingsFor individuals in a primary prevention setting with remnant cholesterol levels at least 95th percentile (≥1.6 mmol/l, 61 mg/dl), 23% of MI and 21% of IHD events developed later were reclassified correctly from below to above 5% for 10-year occurrence when remnant cholesterol levels were added to models based on conventional risk factors, whereas no events were reclassified incorrectly. Overall improved reclassification of MI was also observed for remnant cholesterol levels as low as at least 50th percentile (≥0.6 mmol/l, 25 mg/dl); however, the addition of remnant cholesterol over the entire concentration range yielded insignificant improvements of NRI for MI but slightly improved reclassification of NRI for IHD. In a secondary prevention setting, addition of remnant cholesterol over the entire concentration range to a conventional risk model improved reclassification.SummaryElevated remnant cholesterol levels considerably improves reclassification of individuals who later develop MI and IHD, in primary as well as in secondary prevention settings.",
keywords = "cardiovascular disease, dyslipidemia, guidelines, heart attack, lipids",
author = "Takahito Doi and Nordestgaard, {B{\o}rge G.} and Anne Langsted",
note = "Publisher Copyright: {\textcopyright} 2023 Lippincott Williams and Wilkins. All rights reserved.",
year = "2023",
doi = "10.1097/MED.0000000000000799",
language = "English",
volume = "30",
pages = "128--135",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "2",

}

RIS

TY - JOUR

T1 - Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?

AU - Doi, Takahito

AU - Nordestgaard, Børge G.

AU - Langsted, Anne

N1 - Publisher Copyright: © 2023 Lippincott Williams and Wilkins. All rights reserved.

PY - 2023

Y1 - 2023

N2 - Purpose of reviewTo summarize recent studies analyzing reclassification of estimated risk of myocardial infarction (MI) and ischemic heart disease (IHD) by inclusion of remnant cholesterol (= cholesterol content in triglyceride-rich lipoproteins) in primary and secondary prevention settings.Recent findingsFor individuals in a primary prevention setting with remnant cholesterol levels at least 95th percentile (≥1.6 mmol/l, 61 mg/dl), 23% of MI and 21% of IHD events developed later were reclassified correctly from below to above 5% for 10-year occurrence when remnant cholesterol levels were added to models based on conventional risk factors, whereas no events were reclassified incorrectly. Overall improved reclassification of MI was also observed for remnant cholesterol levels as low as at least 50th percentile (≥0.6 mmol/l, 25 mg/dl); however, the addition of remnant cholesterol over the entire concentration range yielded insignificant improvements of NRI for MI but slightly improved reclassification of NRI for IHD. In a secondary prevention setting, addition of remnant cholesterol over the entire concentration range to a conventional risk model improved reclassification.SummaryElevated remnant cholesterol levels considerably improves reclassification of individuals who later develop MI and IHD, in primary as well as in secondary prevention settings.

AB - Purpose of reviewTo summarize recent studies analyzing reclassification of estimated risk of myocardial infarction (MI) and ischemic heart disease (IHD) by inclusion of remnant cholesterol (= cholesterol content in triglyceride-rich lipoproteins) in primary and secondary prevention settings.Recent findingsFor individuals in a primary prevention setting with remnant cholesterol levels at least 95th percentile (≥1.6 mmol/l, 61 mg/dl), 23% of MI and 21% of IHD events developed later were reclassified correctly from below to above 5% for 10-year occurrence when remnant cholesterol levels were added to models based on conventional risk factors, whereas no events were reclassified incorrectly. Overall improved reclassification of MI was also observed for remnant cholesterol levels as low as at least 50th percentile (≥0.6 mmol/l, 25 mg/dl); however, the addition of remnant cholesterol over the entire concentration range yielded insignificant improvements of NRI for MI but slightly improved reclassification of NRI for IHD. In a secondary prevention setting, addition of remnant cholesterol over the entire concentration range to a conventional risk model improved reclassification.SummaryElevated remnant cholesterol levels considerably improves reclassification of individuals who later develop MI and IHD, in primary as well as in secondary prevention settings.

KW - cardiovascular disease

KW - dyslipidemia

KW - guidelines

KW - heart attack

KW - lipids

U2 - 10.1097/MED.0000000000000799

DO - 10.1097/MED.0000000000000799

M3 - Review

C2 - 36722437

AN - SCOPUS:85148678658

VL - 30

SP - 128

EP - 135

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 2

ER -

ID: 363675094